Please note that some links to federal government websites may be broken due to new presidential executive orders.
breadcrumb
Policies, Procedures, and Guidelines
Related to Applications and Credentialing
- Accreditation of Colleges of Pharmacy (PDF)
- Ancillary Utilization Approval Process for Pharmacy Location Change #48 (PDF)
- Commission Approved Examinations and WAC 246-945-165 and 246-945-205 #P014 (PDF)
- Delegation of Decision-Making to Panels and Health Law Judges for Disciplinary Cases Involving Pharmaceutical Firms and Pharmacy Professionals #P009.2 (PDF)
- Enforcement of AIDS Education and Training Rules – ESHB1551 (PDF)
- Exception Application Guidelines (PDF)
- Guidelines for Diversion Investigation Procedure (PDF)
- Guidelines for Implementation of Pharmacy Technicians Training (PDF)
- Pharmacy Intern Registration BAP (PDF)
- New CE rules – Delayed Effective Date Guidance Document #G001 (PDF)
- New chapter 246-945 supersedes Old WACs #P002 (PDF)
- Non-resident Pharmacy Disciplinary Guidelines (PDF)
- Qualifications for Re-exam – NAPLEX #40 (PDF)
- Verification of Age by Applicant (PDF)
Related to Practice Standards
- CDTA – Guidance on Collaborative Drug Therapy (PDF)
- Commissioner's Statement on Compounding Semaglutide and GLP-1s
- Emergency Medical Reasons – Interpretive Statement (PDF)
- Enforcement of USP General Chapters <795>, <797>, <800>, and <825> (PDF)
- ESRD or Kidney Dialysis Center Authority to Sell, Deliver or Possess Legend Drugs (PDF)
- Euthanasia Training Program Guidelines (PDF)
- Guidance on Mifepristone
- Inspection Requirement for Modifications or Remodels G002.1 (PDF)
- Labeling of Outpatient Medications for Administration #56 (PDF)
- LTC – Chart Orders and the Use of Practitioner Authorized Agent Signatures
- Opioid Overdose Medication – Distribution from Hospital Emergency Departments #59 (PDF)
- Opioid Treatment Program - Drugs that May be Ordered, Possessed and Used by an Opioid Treatment Program DOH-690-329 (PDF)
- Pharmacy Lockers for Filled Prescription Pick-up (PDF)
- Pharmacy Ancillary Personnel Administration of Drugs and Devices Guidelines #G006 (PDF)
- Statement on Compounding Semaglutide and GLP-1s
- Transfer for Initial Dispensing of an Electronic Prescription for a Controlled Substance (PDF)
- Treating Partners of Patients with Sexually Transmitted Chlamydia and Gonorrhea (PDF)